Detection of low-frequency mutations in exon 8 of the TP53 gene by constant denaturant capillary electrophoresis (CDCE)

BioTechniques

Volumn 27, Issue 1, 1999, Pages 128-135

  Ekstrom P O ^a,c   Borresen Dale A L ^a   Qvist, H ^b   Giercksky, K E ^b   Thilly, W G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; DNA DETERMINATION; EXON; FLUORESCENCE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION;

EID: 0033036746     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/99271rr01     Document Type: Article

References (31)

1. Andersen, T.I., R. Holm, J.M. Nesland, K.R. Heimdal, L. Ottestad and A.L. Børresen. 1993. Prognostic significance of TP53 alterations in breast carcinoma. Br. J. Cancer 68:540-548.
2. ATCC. 1992. Cell Lines & Hybridomas. Rockville, MD.
3. Benhattar, J., J.P. Cerottini, E. Saraga, G. Metthez and J.C. Givel. 1996. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int. J. Cancer 69:190-192.
4. Børresen, A.L., T.I. Andersen, J.E. Eyfjord, R.S. Cornelis, S. Thorlacius, A. Borg, U. Johansson, C. Theillet et al. 1995. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosom. Cancer 14:71-75.
5. Børresen, A.L., E. Hovig, S.B. Smith, D. Malkin, S. Lystad, T.I. Andersen, J.M. Nesland, K.J. Isselbacher and S.H. Friend. 1991. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc. Natl. Acad. Sci. USA 88:8405-8409.
6. Brennan, J.A., L. Mao, R.H. Hruban, J.O. Boyle, Y.J. Eby, W.M. Koch, S.N. Goodman and D. Sidransky. 1995. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck [see comments]. N. Engl. J. Med. 332:429-435.
7. Cha, R.S. and W.G. Thilly. 1993. Specificity, efficiency, and fidelity of PCR. PCR Methods Appl. 3:18-29.
8. Feinmesser, R., I. Miyazaki, R. Cheung, J.L. Freeman, A.M. Noyek and H.M. Dosch. 1992. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration [see comments]. N. Engl. J. Med. 326:17-21.
9. Fischer, S.G. and L.S. Lerman. 1983. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc. Natl. Acad. Sci. USA 80:1579-1583.
10. Fixman, M. and J.J. Freire. 1977. Theory of DNA melting curves. Biopolymers 16:2693-2704.
11. Greenblatt, M.S., W.P. Bennett, M. Hollstein and C.C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54:4855-4878.
12. Guldberg, P. and F. Guttler. 1993. A simple method for identification of point mutations using denaturing gradient gel electrophoresis. Nucleic Acids. Res. 21:2261-2262.
13. Hjertén, S. 1985. High-performance electrophoresis elimination of electroendosmosis and solute adsorption. J. Chromatog. 347:191-198.
14. Hollstein, M., D. Sidransky, B. Vogelstein and C.C. Harris. 1991. p53 mutations in human cancers. Science 253:49-53.
15. Hovig, E., S.B. Smith, A. Brøgger and A.L. Børresen. 1991. Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection [published erratum appears in Mutat. Res. 1991. May 263:61]. Mutat. Res. 262:63-71.
16. Khrapko, K., P. Andre, R. Cha, G. Hu and W.G. Thilly. 1994. Mutational spectrometry: means and ends. Prog. Nucleic. Acid Res. Mol. Biol. 49:285-312.
17. Khrapko, K., J.S. Hanekamp, W.G. Thilly, A. Belenkii, F. Foret and B.L. Karger. 1994. Constant denaturant capillary electrophoresis (CDCE): a high resolution approach to mutational analysis. Nucleic Acids Res. 22:364-369.
18. Kumar, R., J.S. Hanekamp, J. Louhelainen, K. Burvall, A. Önfelt, K. Hemminki and W.G. Thilly. 1995. Separation of transforming amino acid-substituting mutations in codons 12, 13 and 61 the N-ras gene by constant denaturant capillary electrophoresis (CDCE). Carcinogenesis 16:2667-2673.
19. Levine, A.J., M.E. Perry, A. Chang, A. Silver, D. Dittmer, M. Wu and D. Welsh. 1994. The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer 69:409-416.
20. Lewin, B. 1994. Genome Size and Genetic Content. Oxford University Press, Oxford.
21. Lundberg, K.S., D.D. Shoemaker, M.W. Adams, J.M. Short, J.A. Sorge and E.J. Mathur. 1991. High-fidelity amplification using a thermostable DNA polymerase isolated from Pymcoccusfuriosus. Gene 108:1-6.
22. Morrin, M., M. Kelly, N. Barrett and P. Delaney. 1994. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut 35:1627-1631.
23. Picard, V., B.E. Ersdal, A. Lu and S.C. Bock. 1994. A rapid and efficient one-tube PCR-based mutagenesis technique using Pfu DNA polymerase. Nucleic Acids. Res. 22:2587-2591.
24. Poland, D. 1974. Recursion relation generation of probability profiles for specific-sequence macromolecules with long-range correlations. Biopolymers 13:1859-1871.
25. Pricolo, V.E., S.D. Finkelstein, T.T. Wu, G. Keller, A. Bakker, P.A. Swalsky and K.I. Bland. 1996. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am. J. Surg. 171:41-46.
26. Riuz, M.M., J. Berka, A. Belenkii, F. Foret, A.W. Miller and B.L. Karger. 1993. DNA sequencing by capillary electrophoresis with replaceable linear polyacrylamide and laser-induced fluorescence detection. Anal. Chem. 65:2851-2858.
27. Sidransky, D., T. Tokino, S.R. Hamilton, K.W. Kinzler, B. Levin, P. Frost and B. Vogeistein. 1992. Identification of ras oncogene mutations in the stool of patients with curable colorectal lumors. Science 256:102-105.
28. Thilly, W.G. 1985. Potential use of gradient denaturing gel electrophoresis in obtaining mutational spectra from human cells. Carcinog. Compr. Surv. 10:511-528.
29. Thorstensen, L., H. Quist, J.M. Nesland, K.-E. Giercksky and R.A. Lothe. 1996. Allelotype profiles of local recurrences and distant metastases from colorectal cancer patients. Int. J. Cancer 69:452-456.
30. Vogelstein, B. 1990. Cancer. A deadly inheritance [news; comment]. Nature 345:681-682.
31. Wattel, E., C. Preudhomme, B. Hecquet, M. Vanrumbeke, B. Quesnel, I. Dervite, P. Morel and P. Fenaux. 1994. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 84:3148-3157.